Usana Health Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Usana Health Sciences (USNA).

Price Target Range — 5 Quarters

Analyst Consensus — 1 Analysts

1Hold

Consensus RatingNeutral# Analysts1Avg. Consensus PT$36Upside to Avg. PT+167.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Feb 27, 2025	DA Davidson	Linda Bolton Weiser	PT Cut	Neutral	$38→$36
Jan 2, 2025	DA Davidson	Linda Bolton Weiser	PT Raise	Neutral	$35→$38
Oct 23, 2024	DA Davidson	Linda Bolton Weiser	PT Cut	Neutral	$38→$35
Jul 25, 2024	DA Davidson	Linda Bolton Weiser	PT Cut	Neutral	$46→$38
May 7, 2024	DA Davidson	Linda Bolton Weiser	PT Cut	Neutral	$48→$46
Feb 22, 2024	DA Davidson	Linda Bolton Weiser	PT Cut	Neutral	$53→$48

Analyst Ratings News

Stock Market Today: Dow Jones, Nasdaq, S&P 500 Futures Advance— Applied Digital, Stellantis, Elastic In Focus (UPDATED)

Editor’s Note: The future prices of benchmark tracking ETFs were updated in the story. U.S. stock futures rose on Friday after closing lower on Thursday’s. Futures of major benchmark indices were higher.

Rishabh Mishra

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $36

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $38 to $36.

Benzinga Newsdesk

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $38

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and raises the price target from $35 to $38.

Benzinga Newsdesk

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $35

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $38 to $35.

Benzinga Newsdesk

Xencor Surges 10.5%: Is This an Indication of Further Gains?

Xencor (NASDAQ: XNCR) shares rallied 10.5% in the last trading session to close at $21.13. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 19.8% gain over the past four weeks.

Zacks

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $38

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $46 to $38.

Benzinga Newsdesk

Usana Health Sciences Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Usana Health Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

Stock Market Today: Dow Jones, Nasdaq, S&P 500 Futures Advance— Applied Digital, Stellantis, Elastic In Focus (UPDATED)

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $36

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $38

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $35

Xencor Surges 10.5%: Is This an Indication of Further Gains?

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $38

People Also Watch

People Also Watch

Usana Health Sciences Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Usana Health Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

Stock Market Today: Dow Jones, Nasdaq, S&P 500 Futures Advance— Applied Digital, Stellantis, Elastic In Focus (UPDATED)

PRODA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $36

PRODA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $38

PRODA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $35

Xencor Surges 10.5%: Is This an Indication of Further Gains?

PRODA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $38

People Also Watch

People Also Watch

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $36

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $38

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $35

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $38